Alex Nikitine

Alex Nikitine

Associé
Dr. iur., LL.M., Avocat

Site

Zurich

Contact

Téléphone direct: +41 58 658 56 32
alex.nikitine@walderwyss.com

Curriculum Vitae

PDF download

Alex Nikitine is head of the Corporate/M&A team at Walder Wyss. His practice focuses on domestic and international M&A transactions, public tender offers, IPOs and other public (ECM/DCM) offerings, private equity and venture capital transactions, corporate governance and general corporate, stock exchange and capital markets laws. His experience for the last 15 years includes numerous transactions in these areas of expertise, in particular with companies in the Life Sciences, Banking or E-Commerce industry.

Alex Nikitine has been recommended by several international directories such as Chambers, IFLR1000 and The Legal 500 as a leading lawyer (by Chambers Global/Europe in both Corporate/M&A and Capital Markets). He is considered "knowledgeable and quick" and "likeable" and is being praised by his "out-of-the-box thinking" and "high level of client orientation" (Chambers, The Legal 500).

Alex Nikitine represents clients in proceedings before the SIX Swiss Exchange, the Swiss Takeover Board (UEK) and the Swiss financial market supervisory authority FINMA. He is a member of the board of examiners for the Swiss certified tax expert exams and a SIX Swiss Exchange recognised representative under art. 58a Listing Rules. He regularly publishes and speaks at conferences in his areas of expertise.

Alex Nikitine studied law at the University of Basel (lic. iur., 2000) and Harvard Law School (LL.M., 2004) and he received a doctorate (PhD; on Swiss and US securities laws) from the University of Zurich (Dr. iur., 2007). In 2009, he worked at Davis Polk & Wardwell LLP in New York, USA.

Alex Nikitine speaks German and English. He is registered with the Zurich Bar Registry and is admitted to practice in Switzerland as well as in the state of New York, USA.

KLAR Partners Acquires BÜHLMANN Laboratories AG

Walder Wyss advised CRISPR Therapeutics (NASDAQ) on USD 280 Million Equity Issuance

ABB acquires Sevensense Robotics

Green Landscaping Group AB (publ) acquires Viva Gartenbau AG

Walder Wyss advised Nasdaq listed Altamira Therapeutics in its sale of majority stake in Altamira Medica

SkyCell AG - USD 57m financing round

Walder Wyss advises WEG S.A. as Swiss counsel in the acquisition of the industrial electric motors and generators business of the Regal Rexnord Corporation

IFLR 1000 Rankings - Walder Wyss as a top-performing law firm ranked

TP24 raises CHF 400m of additional funding from Barclays and M&G

UBS/CS Merger Completed

ITS Kanal Services AG acquires Restclean AG

Walder Wyss advised ANYbotics AG on CHF 45m Series B Round

DSM and Firmenich have completed their EUR 35 bn merger, becoming the leading creation and innovation partner in nutrition, beauty and well-being

ITS Services de Canalisations SA achètent le Groupe Künzli

Swiss medtech company Distalmotion SA closes USD 150m Series F Financing Round

Axiom group acquires Swisslinx

Credit Suisse and UBS to Merge

Cinerius Financial Partners AG acquires a majority stake in Entrepreneur Partners AG

Porsche SE invests in ABB E-mobility’s CHF 325m Pre-IPO Private Placement

Bell Food Group invests in Vertical Farming Start-up YASAI

PostFinance Ventures, Migros and Serpentine Ventures invest in Properti AG

Hotel Saratz Pontresina has new owner

DSM and Firmenich to merge in EUR 42bn transaction, becoming the leading creation and innovation partner in nutrition, beauty and well-being

Zuger Kantonalbank (SIX: ZUGER) is acquiring Immofonds Asset Management AG

Astorg acquires CordenPharma from ICIG

Westhive AG raises over CHF 6 million in series A financing round

Swiss medtech company Distalmotion SA closes USD 90m Series E Financing Round

EH Group raises over CHF 5m Pre-Series A Financing

A.P. Moller Holding acquires Unilabs

Medimaps Group boucle un tour de financement pour un montant de CHF 18.55 millions

Infoniqa acquires Run My Accounts AG

Revalize aquires SpecPage AG

Scanmarket A/S acquires Symfact AG

Polyphor and EnBiotix sign merger agreement and agreement on sale of Murapavadin

Tour de financement série B de Sulzer & Schmid Laboratories AG

Les fonds KLAR Partners achètent ISS Services de Canalisations SA

Infoniqa acquiert Sage Schweiz SA

Walder Wyss AG a conseillé le dirigeant de consortium dans le cadre de l’émission de droits de souscription de Swiss Steel Group

Walder Wyss conseille CRISPR sur le programme de vente d’actions « ATM » de 600 millions USD

Tour de table série B de 7,8 millions CHF de 1plusX AG

Walder Wyss conseille CRISPR sur le programme de vente d’actions « ATM » de 350 millions USD

Walder Wyss conseille ANYbotics AG dans un tour de financement de série A de CHF 20 millions

Tour de financement de série B de CH 14 millions de Memo Therapeutics

Walder Wyss conseille CRISPR dans le cadre d’une offre d’actions à USD 520 millions

Sunrise reprend le pionner de la web-tv Wilmaa

Celanese Corporation (NYSE : CE) réussit l’acquisition de l’activité de poudres de polymères redispersables Elotex de Nouryon

Walder Wyss a conseillé Long State Investment Limited (LSI) dans le cadre de son investissement de près de 31 millions CHF dans le capital de WISeKey International Holding Ltd (WISeKey)

Walder Wyss conseille CRISPR concernant l’émission d’actions pour une valeur d’USD 310 mio

Achat de Klinik Gais AG, kardiale Rehabilitation, Psychosomatik und Psychotherapie

Walder Wyss advises Nestlé on CHF 10.2 billion sale of Skin Health Business

Beekeeper boucle un tour de financement pour un montant de USD 45 millions

Walder Wyss conseille CRISPR dans le cadre du programme de vente d’actions «ATM» pour une valeur d’USD 200 mio

SWISSTO12 boucle un tour de financement pour un montant de CHF 18.1 millions

Sobi acquiert le département d’immunologie de NovImmune dans le cadre d’une transaction de CHF 515 mio.

La start-up FinTech Tradeplus24 créée en Suisse a finalisé un tour de financement de série A de CHF 120 mio.

Tour de financement de CHF 15,5 mio de la start-up suisse Oculis SA

Le géant chinois des technologies Baidu investit dans la start-up suisse aiCTX

Walder Wyss advised 40 North in the acquisition and subsequent sale of shares in Clariant AG

IPO de Medartis à SIX Swiss Exchange

Swiss Auris Medical Holding AG (Nasdaq) implements Reverse Share Split through Intra-Group Merger

Tamedia entend reprendre la régie publicitaire médias Goldbach Group (SIX: GBMN)

Metall Zug (SIX: METN) rachète la majorité des parts de Haag-Streit Holding AG

Le groupe AMEOS rachète l'hôpital suisse Seeklink Brunnen

Walder Wyss conseille Evolute Group AG lors de l’exécution du premier tour des CHF 6 millions

Cembra Money Bank reprend SWISSBILLING SA, une prestataire de financement de factures

Auris Medical's Public Equity Offering

Les emprunts d'une somme de CHF 100 mio. de Zug Estates

Baloîse reprend Pax Anlage AG

Apax / Unilabs

Fairfax Financial fusionne avec Allied World de Suisse pour un montant d'USD 4,9 mia en espèces et en actions

Intégration totale d’e-fon SA dans UPC Suisse

Ascom vend sa division Tests de réseau à InfoVista

Auris Medical launches ATM Offering

Swiss Life - CHF 600 mio. Hybrid Bonds

Web TV Joint Venture Wilmaa & Teleboy

Bayer et CRISPR Therapeutics créent une coentreprise d’édition génomique

Management buy-out Swisscanto/Banque cantonale de Zurich

Fusion Going Private transfrontalière pour SHL Telemedecine Ltd. (SIX: SHLTN)

Computershare acquiert SIX SAG SA

Swiss Life: obligation hybride de EUR 750 millions

Life Invest Holding AG rachète Skandia Vie SA

Valens Clinics acquire Rheinburg Clinics

Evolva acquires Allylix in Share Exchange Transaction

IPO of Glarner Kantonalbank

L’Oréal purchases Decléor and Carita from Shiseido

Novadaq aquires Aïmago SA

HgCapital acquires 91.85% in P&I Personal & Informatik AG and launches public tender offer

Swiss Life Holding AG issued CHF 500 million Convertible Bonds

IPO Cembra Money Bank

upc cablecom acquires 49%-stake in e-fon AG

Ammann Group sells Implenia stake in Accelerated Bookbuilding Transaction

Sale of Hospital Villa im Park to Genolier Group

Volvo Auto Bank Deutschland transfers Swiss Leasing and Dealer Wholesale Business to FCE Bank

Swiss Life Holding AG issued two Senior Bonds in the amount of CHF 425 million

Swiss Life closed CHF 800 million Loan Exchange Transaction

Swiss Life AG issued a CHF 300 million hybrid bond

Chambers Venture Capital 2024 Global Practice Guide

Interview (in German) with Alex Nikitine in “Finanz & Wirtschaft”

Commentary on Art. 689b, 689c and 689f of the Swiss Code of Obligations (Representation of shareholders; independent voting representative in public companies; disclosure)

Best Price Rule in Public Takeovers – MINOR Changes, MAJOR Effect

Different Requirements for Different Opting Out Clauses under Swiss Public Takeover Rules

Liquidation of unprofitable business by the target company as a permissible condition to a public offer

Liquidation of unprofitable business by the target company as a permissible condition to a public offer

Negotiations in M&A transactions - tips and tricks

Article 725 et seq. CO: (Il-)Liquidity, Capital Loss and Over-Indebtedness – New Duties for Swiss Boards

Commentaire sur les articles 64, 65 et 68 de la loi fédérale sur les établissements financiers (LEFin)

« Officer’s Certificates » dans des transactions M&A

Les règles révisées de la SIX sur la publicité ad hoc entrent en vigueur au 1er juillet 2021

IPO Readiness - Stolpersteine auf dem Weg zum Börsengang

Covid-19 Update: Emergency Loan Scheme for Start-ups

Guidelines on Shareholders’ Meetings under COVID-19 Ordinance 2

Règles de déclaration modifiées dans le cadre du droit suisse des sociétés («règles GAFI»); des sanctions pénales vont s’appliquer

Il successo dei nostri “startupper” è la più grande motivazione

Initial Public Offering (IPO) 2017 / Switzerland

IPO Guide Switzerland (SIX Swiss Exchange) / Listing Requirements by the SIX Swiss Exchange

Commentaire sur la loi sur l"infrastructure des marchés financiers (LIMF)

Management Buy-out - Pre-Contractual Disclosure Obligations of the Managers

Wealth Tax on Shares in Start-ups – New Rules in the Canton of Zurich

Mergers & Acquisitions Practice Area Review

Changes to Swiss Rules on Disclosure of qualified Shareholdings

Commentary on articles 8-11, 30 VegüV

Venture capital investment in Switzerland: market and regulatory overview

Mergers & Acquisitions Practice Area Review

Adjustments to the Swiss Corporate Governance Framework

Cross-Border Equity Capital Markets – Switzerland

Debatte über neue Spielregeln durch die Minder-Initiative

Der unabhängige Stimmrechtsvertreter in der Verordnung gegen übermässige Vergütungen bei börsenkotierten Aktiengesellschaften (VegüV): Überblick – herausgegriffene Fragen – Lösungsansätze

Umsetzung der «Abzocker-Initiative» – Die VegüV liegt vor.

Verletzung der Meldepflicht (Art. 20 BEHG) und der bankenrechtlichen Gewährspflicht/Entscheidbesprechung BVGE 2012/33

Draft Ordinance on Minder Initiative: No groundbreaking rules; interesting clarifications.

Venture capital investment in Switzerland: market and regulatory overview

Revision des Schweizer Börsenrechts und Corporate Governance Regeln

Minder initiative approved – New Corporate Governance Rules for Swiss Public Companies

Cross-Border Equity Capital Markets – Switzerland

SIX Swiss Exchange: Yes to Attorney Work Product Privilege in Investigations by the SIX and Yes to Substantial Fines for Breaches of the SIX Listing Rules

Use of Share Purchase Agreements in European Jurisdictions: Switzerland

Fusion – Angebotspflicht – Opting-out

USA – Gesetzliche Regulierung der Management-Vergütung

The liability of the Board of Directors and Managers under Article 754 para. 1 CO for business judgements: Concept and structure of the business judgement rule in the Corporate Governance context

Golden Handshakes, Golden Parachutes and similar arrangements in M&A transactions

Reconnaissances


Autres avocats